Bittersweet victory for GSK’s Avandia
Friday, July 16, 2010 - 10:56
in Health & Medicine
GlaxoSmithKline’s diabetes drug looks set to remain on the market, but the firm is facing over £1.5 billion in various legal bills and settlements